Table 5.
Univariate analysis of probability of treatment success.
| Probability | 95% CI | p-Value | ||
|---|---|---|---|---|
| All patients | 96% | 93–99 | ||
| Virus | RSV+ | 94% | 87–98 | 0.26 |
| RSV− | 98% | 95–100 | ||
| Gender | Male | 95% | 91–99 | 0.40 |
| Female | 96% | 91–100 | ||
| Fever | Yes | 98% | 94–100 | 0.42 |
| No | 95% | 91–99 | ||
| pCO2 >50 mmHg | Yes | 91% | 88–93 | 0.03 |
| No | 98% | 95–100 | ||
| Low-Flow Oxygen | Yes | 96% | 93–100 | 0.25 |
| No | 94% | 89–100 | ||
| High-Flow Oxygen | Yes | 81% | 69–93 | 0.005 |
| No | 100% | |||
| Weight-for-age | AGA | 95% | (91–99) | 0.10 |
| SGA | 100% | |||
| LGA | 100% | |||
| Diet | Breast milk | 95% | 92–99 | 0.85 |
| Infant formula | 95% | 89–100 | ||
| Weaned baby | 94% | 83–100 | ||
| Antibiotics | Yes | 100% | 0.06 | |
| No | 94% | 90–98 | ||
| Steroids | Yes | 92% | 81–100 | 0.59 |
| No | 96% | 93–99 | ||
| Patient’s age | <1 month | 83% | 69–99 | 0.045 |
| 1–3 months | 97% | 95–100 | ||
| 4–6 months | 100% | |||
| >6 months | 94% | 83–100 |
AGA: appropriate for gestational age. SGA: small for gestational age. LGA: large for gestational age.